AtriCure Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.5% | 3.8% | -20.1% | 6.3% | 17.3% | 4.7% | -8.9% | 15.9% | 19.9% | 14.3% | -2.8% | 14.4% | 11.4% | |
| 4.2% | 3.9% | 4.1% | 3.9% | 4.3% | 3.9% | 4.1% | 3.8% | 3.8% | 3.6% | 3.7% | 3.5% | 3.7% | |
| 8.8% | 8.7% | 8.5% | 8.9% | 8.9% | 8.4% | 7.8% | 8.4% | 9.3% | 8.0% | 8.0% | 8.0% | 8.3% | |
| -3.0% | -0.5% | -21.4% | 0.1% | 10.6% | -5.9% | -15.9% | 4.6% | 6.6% | 0.1% | -15.2% | -2.9% | -3.0% | |
| 3.7% | 2.6% | 2.5% | 2.1% | 3.1% | 11.8% | 1.8% | 5.6% | 1.9% | 2.4% | 2.7% | 2.5% | 2.4% | |
| 12.1% | -2.6% | 8.9% | 26.6% | 3.8% | -11.8% | -1.4% | -5.6% | -1.9% | -1.9% | -2.7% | -2.5% | -2.3% | |
| 0.8% | 2.2% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -0.4% | -0.1% | -6.0% | -0.1% | -0.1% | -0.2% | -8.2% | -0.3% | -0.3% | -0.2% | -8.1% | -0.2% | -2.2% | |
| – | – | – | – | -0.2% | -0.2% | -0.2% | -0.2% | -0.2% | -0.2% | -0.8% | -0.2% | -0.4% | |
| 0.1% | 2.2% | -6.4% | 2.5% | -0.3% | 1.4% | -8.4% | 2.5% | 4.5% | 1.5% | -9.4% | 2.1% | -0.3% | |
| 13.6% | 3.5% | -17.8% | 35.3% | 21.0% | -6.1% | -18.5% | 13.2% | 22.4% | 13.9% | -15.1% | 14.1% | 8.8% | |
| -2.1% | 1.2% | -22.6% | 4.3% | 14.1% | -7.1% | -10.7% | 10.3% | 18.0% | 16.7% | -5.6% | 12.0% | 10.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.